NFGH
KYMR icon

Nan Fung Group Holdings’s Kymera Therapeutics KYMR Stock Holding History

Nan Fung Group Holdings’s Portfolio KYMR Stock Details KYMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.57M Hold
30,875
– – 2.12% 12
2025
Q4 		$2.4M Hold
30,875
– – 2.15% 15
2025
Q3 		$1.75M Hold
30,875
– – 2.93% 13
2025
Q2 		$1.35M Hold
30,875
– – 2.12% 13
2025
Q1 		$845K Hold
30,875
– – 0.69% 25
2024
Q4 		$1.24M Buy
30,875
+20,000
+184% +$903K 1.06% 24
2024
Q3 		$515K Hold
10,875
– – 0.44% 30
2024
Q2 		$325K Hold
10,875
– – 0.35% 31
2024
Q1 		$437K Buy
+10,875
New +$389K 0.41% 34
2022
Q1 		– Sell
-4,960
Closed -$315K – 51
2021
Q4 		$315K Buy
+4,960
New +$289K 0.09% 39

Other funds holding KYMR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Nan Fung Group Holdings's KYMR Position: Q1 2026 in Review

Nan Fung Group Holdings held its Kymera Therapeutics (KYMR) position steady in Q1 2026 at 30,875 shares worth $2.57M. The position accounts for 2.12% of the portfolio, ranked #12.

Nan Fung Group Holdings first reported a position in KYMR in Q4 2021 and has held it in 10 quarters since. 256 funds tracked by Wall St. Rank hold KYMR as of Q1 2026.

  • Nan Fung Group Holdings held 30,875 shares of Kymera Therapeutics worth $2.57M as of Q1 2026.
  • Nan Fung Group Holdings left its Kymera Therapeutics share count unchanged in Q1 2026.
  • Kymera Therapeutics made up 2.12% of Nan Fung Group Holdings's portfolio in Q1 2026, its #12 holding.
  • Nan Fung Group Holdings first reported a position in Kymera Therapeutics in Q4 2021 and has held it in 10 quarters since.
  • 256 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q1 2026.

Based on Nan Fung Group Holdings's 13F filing for Q1 2026, filed 14 May 2026.